|
KR20080079592A
|
|
Recombinant mammalian cell for screening a substance preventing and treating aids and screening method using the same
|
|
US2010047865A1
|
|
Vector for expressing NC protein of HIV and method for producing NC protein using the same
|
|
KR20080076614A
|
|
Composition for preventing and treating aids comprising hivnc protein
|
|
KR20080057750A
|
|
Vector for expressing nc protein of hiv and method for producing nc protein using the same
|
|
KR20080057751A
|
|
Codon-optimized hiv nc poly-nucleotide, vector containing said poly-nucleotide and method for producing nc protein using the same
|
|
KR20060011602A
|
|
Nc mutants having an enhanced binding activity to hiv psi and pharmaceutical composition comprising the same
|
|
KR20050022417A
|
|
A Transformant for Screening HIV Inhibitor
|
|
KR20030082191A
|
|
Protein for Binding to NC Protein of HIV-1
|
|
KR20010090959A
|
|
A Transformant for Screening of Inhibitor for Human Immunodeficiency Virus
|
|
KR20010094219A
|
|
Method for Determining Drug Susceptibility of Mycobacterium leprae by RT-PCR
|
